Showing results (531-540 of 561) with videos related to
Sort By:
Pageof 57
Ecology|March 17, 2025
Phenological sensitivity of Bromus tectorum genotypes depends on current and source environmentsMegan L Vahsen, Toby M Maxwell, Dana M Blumenthal, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 11, 2015
FDA approval: ceritinib for the treatment of metastatic anaplastic lymphoma kinase-positive non-small cell lung cancerSean Khozin, Gideon M Blumenthal, Lijun Zhang, et al.The Oncologist|July 1, 2021
Systematic Review of PD-1/PD-L1 Inhibitors in Oncology: From Personalized Medicine to Public HealthElaine Chang, Lorraine Pelosof, Steven Lemery, et al.Ecology Letters|January 26, 2013
Life-history constraints in grassland plant species: a growth-defence trade-off is the normEric M Lind, Elizabeth Borer, Eric Seabloom, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 27, 2013
First FDA approval of dual anti-HER2 regimen: pertuzumab in combination with trastuzumab and docetaxel for HER2-positive metastatic breast cancerGideon M Blumenthal, Nancy S Scher, Patricia Cortazar, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 14, 2018
FDA Approval: Ribociclib for the Treatment of Postmenopausal Women with Hormone Receptor-Positive, HER2-Negative Advanced or Metastatic Breast CancerAnand Shah, Erik Bloomquist, Shenghui Tang, et al.Nature Plants|February 10, 2019
Globally consistent influences of seasonal precipitation limit grassland biomass response to elevated CO2Mark J Hovenden, Sebastian Leuzinger, Paul C D Newton, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 11, 2018
U.S. Food and Drug Administration Approval: Neratinib for the Extended Adjuvant Treatment of Early-Stage HER2-Positive Breast CancerHarpreet Singh, Amanda J Walker, Laleh Amiri-Kordestani, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 14, 2018
FDA Approval Summary: (Daunorubicin and Cytarabine) Liposome for Injection for the Treatment of Adults with High-Risk Acute Myeloid LeukemiaAviva C Krauss, Xin Gao, Liang Li, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|July 13, 2016
Clinician Perspectives on Current Issues in Lung Cancer Drug DevelopmentSaiama N Waqar, Philip D Bonomi, Ramaswamy Govindan, et al.Pageof 57